Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Giles

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 19, 2014
Vascular stiffness is a biomarker of global cardiovascular riskGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2010
Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension? Messages from ALLHAT, ACCOMPLISH, and ACCORDThomas D Giles, Mark C Houston
The American Journal of Geriatric Cardiology|July 23, 2004
Ximelagatran: light at the end of the tunnel or the next tunnel?Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology|May 12, 2005
Alcohol--a cardiovascular drug?Thomas D Giles, Gary E Sander
Journal of Clinical Hypertension (Greenwich, Conn.)|March 6, 2013
Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it rightThomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|September 6, 2002
HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology|January 5, 2002
Angiotensin II (AT(1)) receptor antagonists, diabetes, and nephropathy: do differences between the renal and systemic circulations explain the outcomes observed with ARBs and ACE inhibitors?Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|January 1, 1993
Aspects of the Use of Angiotensin-Converting Enzyme Inhibitors and Calcium Antagonists in Treatment of Heart Failure in the Older PatientThomas D Giles, Gary E. Sander
The American Journal of Geriatric Cardiology|July 31, 2003
ALLHAT and ANBP2: what have we learned from recent mega-trials?Gary E Sander, Thomas D Giles
Current Hypertension Reports|November 7, 2002
Hypertension and lipids: lipid factors in the hypertension syndromeGary E Sander, Thomas D Giles
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Hypertension (Greenwich, Conn.)|August 19, 2014
Vascular stiffness is a biomarker of global cardiovascular riskGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2010
Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension? Messages from ALLHAT, ACCOMPLISH, and ACCORDThomas D Giles, Mark C Houston
The American Journal of Geriatric Cardiology|July 23, 2004
Ximelagatran: light at the end of the tunnel or the next tunnel?Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology|May 12, 2005
Alcohol--a cardiovascular drug?Thomas D Giles, Gary E Sander
Journal of Clinical Hypertension (Greenwich, Conn.)|March 6, 2013
Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it rightThomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|September 6, 2002
HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?Gary E Sander, Thomas D Giles
The American Journal of Geriatric Cardiology|January 5, 2002
Angiotensin II (AT(1)) receptor antagonists, diabetes, and nephropathy: do differences between the renal and systemic circulations explain the outcomes observed with ARBs and ACE inhibitors?Thomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|January 1, 1993
Aspects of the Use of Angiotensin-Converting Enzyme Inhibitors and Calcium Antagonists in Treatment of Heart Failure in the Older PatientThomas D Giles, Gary E. Sander
The American Journal of Geriatric Cardiology|July 31, 2003
ALLHAT and ANBP2: what have we learned from recent mega-trials?Gary E Sander, Thomas D Giles
Current Hypertension Reports|November 7, 2002
Hypertension and lipids: lipid factors in the hypertension syndromeGary E Sander, Thomas D Giles
Pageof 15